Can elevated TSH with normal free T4 and DIO2 rs225014 CT suggest tissue-level thyroid hormone signaling inefficiency?

The DIO2 rs225014 (Thr92Ala) polymorphism impairs intracellular type 2 deiodinase (D2) activity, creating a state of localized, tissue-specific hypothyroidism that is often masked by normal circulating thyroid hormone levels.

Local Deiodination and Pituitary Feedback

• The DIO2 rs225014 CT genotype leads to structural alteration, Golgi mislocalization, and accelerated degradation of the D2 enzyme, while triggering endoplasmic reticulum stress and the unfolded protein response.
• This genetic variation reduces intracellular T4-to-T3 conversion by 20% to 40%, creating a localized T3 deficit in target tissues.
• Because the pituitary gland relies on local, D2-mediated conversion to regulate negative feedback, it senses this intracellular T3 deficiency and increases TSH secretion, presenting clinically as elevated TSH despite optimal circulating free T4.

Mitochondrial Energy Production

• Local T3 activation is a critical regulator of cellular bioenergetics. Inefficient local T4-to-T3 conversion reduces the expression of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α).
• Decreased PGC-1α downregulates mitochondrial transcription factor A (TFAM), a master regulator of mitochondrial DNA transcription, replication, and respiratory chain activity.
• This signaling impairment ultimately blunts mitochondrial enzyme activity, leading to a reduced oxygen consumption rate (OCR) and diminished capacity for cellular ATP production.

Bottom line

• The DIO2 rs225014 CT polymorphism represents a clinically relevant genetic barrier to local thyroid hormone activation. This tissue-level conversion inefficiency is characterized by elevated TSH alongside optimal free T4, and it directly compromises the PGC-1α-TFAM pathway to impair mitochondrial biogenesis and cellular energy output.